As of Oct 02
| +0.47 / +8.35%|
The 3 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 19.00 and a low estimate of 11.00. The median estimate represents a +96.72% increase from the last price of 6.10.
The current consensus among 3 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.